Stewart Campbell Email & Phone Number | At Axial, we are pioneering a new generation of Microbial-Inspired Therapeutics. We’re proud to be a scientific leader focusing on the interface between the microbiome and the human body. Rooted in a decade of ground-breaking research, our team employs unique and proprietary preclinical models to identify and validate targets and generate drug candidates designed to address the microbiome-driven pathology of a particular disease. Our Microbial-Inspired Therapeutics discovery platform has the potential to treat any disease impacted by the microbiome. We are focused on translating our platform into a clinical pipeline of small molecule therapeutics with an initial focus on autism (Phase 2) and Parkinson’s disease, and with emerging programs in liver disease and oncology. Learn more at www.axialtx.com.

Stewart Campbell

At Axial, we are pioneering a new generation of Microbial-Inspired Therapeutics. We’re proud to be a...
Greater Boston, Greater Boston, United States

*50 free lookup(s) per month.

Stewart Campbell’s Phone Numbers

Get STEWART’s Phone Number (For Free)

Social Media

Stewart Campbell’s Location Greater Boston, Greater Boston, United States

Stewart Campbell’s Current Industry Axial Therapeutics Axial Biotherapeutics

Find accurate emails & phone numbers for over 700M professionals.

Chief Executive Officer

2021-02-01 00:00:00 - Present

Senior Vice President Preclinical R&D

2018-12-01 00:00:00 - Present

Head, Business Development and Product Management, Carbohydrates

2013-11-01 00:00:00 - 2017-02-01 00:00:00

Vice President, Research & Development

2006-10-01 00:00:00 - 2013-10-01 00:00:00

Vice President, Chemistry & Preclinical Development

2000-10-01 00:00:00 - 2006-10-01 00:00:00

Director, Technical Operations

1997-01-01 00:00:00 - 2000-10-01 00:00:00

Scientific Advisory Board

1996-01-01 00:00:00 - 2000-01-01 00:00:00

Scientist

1995-01-01 00:00:00 - 1997-01-01 00:00:00

No Skills Available

No Languages Available

Stewart Campbell is a At Axial, we are pioneering a new generation of Microbial-Inspired Therapeutics. We’re proud to be a scientific leader focusing on the interface between the microbiome and the human body. Rooted in a decade of ground-breaking research, our team employs unique and proprietary preclinical models to identify and validate targets and generate drug candidates designed to address the microbiome-driven pathology of a particular disease. Our Microbial-Inspired Therapeutics discovery platform has the potential to treat any disease impacted by the microbiome. We are focused on translating our platform into a clinical pipeline of small molecule therapeutics with an initial focus on autism (Phase 2) and Parkinson’s disease, and with emerging programs in liver disease and oncology. Learn more at www.axialtx.com.

Stewart Campbell currently works in the Axial Therapeutics | Axial Biotherapeutics |

Stewart Campbell has prior
experience in the following industries:
Cordenpharma | Ancora Pharmaceuticals | Surface Logix | Insmed | Natural Products And Glycotechnology Research Institute Durham Nc | Boehringer Ingelheim

Stewart Campbell has the following professional experience:
Axial Therapeutics | Axial Biotherapeutics | Cordenpharma | Ancora Pharmaceuticals | Surface Logix | Insmed | Natural Products And Glycotechnology Research Institute Durham Nc | Boehringer Ingelheim